HEADER DNA BINDING PROTEIN 23-OCT-15 5AZT TITLE TERNARY COMPLEX OF HPPARALPHA LIGAND BINDING DOMAIN, 17-OXODHA AND A TITLE 2 SRC1 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 201-468; COMPND 5 SYNONYM: PPAR-ALPHA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: 15-MERIC PEPTIDE FROM NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 10 CHAIN: C; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARA, NR1C1, PPAR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606 KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, LIGAND BINDING DOMAIN, KEYWDS 2 ZINC-FINGER, DNA BINDING, TRANSCRIPTION, OBESITY, NUCLEUS, RECEPTOR, KEYWDS 3 ACTIVATOR, OXIDIZED FATTY ACID, TRANSCRIPTION FACTOR, AGONIST, DUAL KEYWDS 4 AGONIST, COVALENT, PPRE, NUCLEAR, CO-ACTIVATOR, DNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.EGAWA,T.ITOH,K.YAMAMOTO REVDAT 3 26-FEB-20 5AZT 1 REMARK REVDAT 2 13-JUL-16 5AZT 1 JRNL REVDAT 1 06-JUL-16 5AZT 0 JRNL AUTH D.EGAWA,T.ITOH,Y.AKIYAMA,T.SAITO,K.YAMAMOTO JRNL TITL 17-OXODHA IS A PPAR ALPHA/GAMMA DUAL COVALENT MODIFIER AND JRNL TITL 2 AGONIST JRNL REF ACS CHEM.BIOL. 2016 JRNL REFN ESSN 1554-8937 JRNL PMID 27337155 JRNL DOI 10.1021/ACSCHEMBIO.6B00338 REMARK 2 REMARK 2 RESOLUTION. 3.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0103 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 11.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 7408 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.255 REMARK 3 R VALUE (WORKING SET) : 0.253 REMARK 3 FREE R VALUE : 0.308 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 400 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.53 REMARK 3 REFLECTION IN BIN (WORKING SET) : 476 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.81 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE SET COUNT : 18 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4046 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 24 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.51000 REMARK 3 B22 (A**2) : 0.51000 REMARK 3 B33 (A**2) : -1.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.823 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.650 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 40.739 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.853 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.740 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4182 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4101 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5644 ; 1.257 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9412 ; 2.124 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 521 ; 4.777 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 174 ;39.651 ;24.943 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 736 ;19.142 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;20.950 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 664 ; 0.071 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4674 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 920 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2096 ; 1.217 ; 3.164 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2095 ; 1.215 ; 3.163 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2613 ; 2.105 ; 4.735 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2614 ; 2.104 ; 4.737 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2086 ; 1.564 ; 3.222 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2084 ; 1.562 ; 3.220 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3031 ; 2.359 ; 4.806 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5065 ; 4.276 ;25.033 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5066 ; 4.276 ;25.039 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5AZT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-OCT-15. REMARK 100 THE DEPOSITION ID IS D_1300000288. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8185 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.450 REMARK 200 RESOLUTION RANGE LOW (A) : 47.610 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 10.50 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, 35% PEG3350, PH 6.9, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 158.97000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 29.73000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 29.73000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 79.48500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 29.73000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 29.73000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 238.45500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 29.73000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 29.73000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 79.48500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 29.73000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 29.73000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 238.45500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 158.97000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 200 REMARK 465 ALA A 201 REMARK 465 ASP A 202 REMARK 465 LEU A 203 REMARK 465 SER A 230 REMARK 465 GLY A 231 REMARK 465 LYS A 232 REMARK 465 ALA A 233 REMARK 465 GLY B 200 REMARK 465 ALA B 201 REMARK 465 ASP B 202 REMARK 465 LEU B 203 REMARK 465 ASN B 235 REMARK 465 VAL B 255 REMARK 465 ALA B 256 REMARK 465 LYS B 257 REMARK 465 LEU B 258 REMARK 465 VAL B 259 REMARK 465 ALA B 260 REMARK 465 ASN B 261 REMARK 465 GLY B 262 REMARK 465 ILE B 263 REMARK 465 GLN B 264 REMARK 465 ASN B 265 REMARK 465 MET B 467 REMARK 465 TYR B 468 REMARK 465 LEU C 683 REMARK 465 THR C 684 REMARK 465 GLU C 685 REMARK 465 GLY C 697 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 204 CG CD CE NZ REMARK 470 LYS A 208 CG CD CE NZ REMARK 470 ARG A 209 CG CD NE CZ NH1 NH2 REMARK 470 VAL A 227 CG1 CG2 REMARK 470 ASN A 303 CG OD1 ND2 REMARK 470 GLU A 342 CG CD OE1 OE2 REMARK 470 ASP A 371 CG OD1 OD2 REMARK 470 LYS A 399 CG CD CE NZ REMARK 470 GLN A 442 CG CD OE1 NE2 REMARK 470 LYS A 449 CG CD CE NZ REMARK 470 ARG A 465 CG CD NE CZ NH1 NH2 REMARK 470 TYR A 468 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 204 CG CD CE NZ REMARK 470 LYS B 208 CG CD CE NZ REMARK 470 ARG B 209 CG CD NE CZ NH1 NH2 REMARK 470 SER B 234 OG REMARK 470 GLU B 251 CG CD OE1 OE2 REMARK 470 LYS B 252 CG CD CE NZ REMARK 470 HIS B 396 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 399 CG CD CE NZ REMARK 470 GLU B 402 CG CD OE1 OE2 REMARK 470 ASP B 418 CG OD1 OD2 REMARK 470 PHE B 421 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN B 435 CG CD OE1 NE2 REMARK 470 GLN B 445 CG CD OE1 NE2 REMARK 470 LYS B 449 CG CD CE NZ REMARK 470 ARG C 686 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 688 CG CD CE NZ REMARK 470 GLU C 696 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 261 8.42 83.79 REMARK 500 LYS A 266 -0.90 85.06 REMARK 500 PRO B 237 151.45 -46.23 REMARK 500 GLU B 369 39.46 70.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4M5 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4M5 B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AZV RELATED DB: PDB DBREF 5AZT A 201 468 UNP Q07869 PPARA_HUMAN 201 468 DBREF 5AZT B 201 468 UNP Q07869 PPARA_HUMAN 201 468 DBREF 5AZT C 683 697 UNP Q15788 NCOA1_HUMAN 683 697 SEQADV 5AZT GLY A 200 UNP Q07869 EXPRESSION TAG SEQADV 5AZT LEU A 423 UNP Q07869 PHE 423 ENGINEERED MUTATION SEQADV 5AZT GLY B 200 UNP Q07869 EXPRESSION TAG SEQADV 5AZT LEU B 423 UNP Q07869 PHE 423 ENGINEERED MUTATION SEQRES 1 A 269 GLY ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU SEQRES 2 A 269 ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA SEQRES 3 A 269 ARG VAL ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO SEQRES 4 A 269 PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU SEQRES 5 A 269 LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN SEQRES 6 A 269 ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN SEQRES 7 A 269 CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU PHE SEQRES 8 A 269 ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN SEQRES 9 A 269 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA SEQRES 10 A 269 ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP GLY SEQRES 11 A 269 MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU SEQRES 12 A 269 PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET SEQRES 13 A 269 GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU SEQRES 14 A 269 GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA SEQRES 15 A 269 ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL SEQRES 16 A 269 GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL SEQRES 17 A 269 LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE SEQRES 18 A 269 PHE LEU LEU PRO LYS LEU LEU GLN LYS MET ALA ASP LEU SEQRES 19 A 269 ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE SEQRES 20 A 269 ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU SEQRES 21 A 269 LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 B 269 GLY ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU SEQRES 2 B 269 ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA SEQRES 3 B 269 ARG VAL ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO SEQRES 4 B 269 PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU SEQRES 5 B 269 LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN SEQRES 6 B 269 ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN SEQRES 7 B 269 CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU PHE SEQRES 8 B 269 ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN SEQRES 9 B 269 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA SEQRES 10 B 269 ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP GLY SEQRES 11 B 269 MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU SEQRES 12 B 269 PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET SEQRES 13 B 269 GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU SEQRES 14 B 269 GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA SEQRES 15 B 269 ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL SEQRES 16 B 269 GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL SEQRES 17 B 269 LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE SEQRES 18 B 269 PHE LEU LEU PRO LYS LEU LEU GLN LYS MET ALA ASP LEU SEQRES 19 B 269 ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE SEQRES 20 B 269 ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU SEQRES 21 B 269 LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 C 15 LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN SEQRES 2 C 15 GLU GLY HET 4M5 A 501 25 HET 4M5 B 501 25 HETNAM 4M5 (4~{Z},7~{Z},10~{Z},13~{Z},19~{Z})-17- HETNAM 2 4M5 OXIDANYLIDENEDOCOSA-4,7,10,13,19-PENTAENOIC ACID FORMUL 4 4M5 2(C22 H32 O3) FORMUL 6 HOH *24(H2 O) HELIX 1 AA1 LYS A 204 PHE A 218 1 15 HELIX 2 AA2 ASN A 221 LEU A 229 1 9 HELIX 3 AA3 ASP A 243 THR A 253 1 11 HELIX 4 AA4 THR A 253 ALA A 260 1 8 HELIX 5 AA5 GLU A 267 ILE A 294 1 28 HELIX 6 AA6 ASP A 301 SER A 322 1 22 HELIX 7 AA7 ARG A 341 LEU A 347 1 7 HELIX 8 AA8 PRO A 350 ASP A 353 5 4 HELIX 9 AA9 ILE A 354 ALA A 367 1 14 HELIX 10 AB1 ASP A 371 CYS A 384 1 14 HELIX 11 AB2 ASN A 393 HIS A 416 1 24 HELIX 12 AB3 PHE A 421 GLU A 451 1 31 HELIX 13 AB4 HIS A 457 ARG A 465 1 9 HELIX 14 AB5 SER B 205 PHE B 218 1 14 HELIX 15 AB6 ASN B 221 GLY B 231 1 11 HELIX 16 AB7 ASP B 243 LEU B 254 1 12 HELIX 17 AB8 GLU B 267 ILE B 294 1 28 HELIX 18 AB9 GLY B 296 LEU B 300 5 5 HELIX 19 AC1 ASP B 301 SER B 322 1 22 HELIX 20 AC2 ARG B 341 LEU B 347 1 7 HELIX 21 AC3 PRO B 350 ASP B 353 5 4 HELIX 22 AC4 ILE B 354 ALA B 367 1 14 HELIX 23 AC5 ASP B 371 CYS B 384 1 14 HELIX 24 AC6 ASN B 393 HIS B 416 1 24 HELIX 25 AC7 PHE B 421 GLU B 451 1 31 HELIX 26 AC8 HIS B 457 ARG B 465 1 9 HELIX 27 AC9 HIS C 687 GLU C 696 1 10 SHEET 1 AA1 3 PHE A 239 ILE A 241 0 SHEET 2 AA1 3 GLY A 337 THR A 340 1 O PHE A 338 N PHE A 239 SHEET 3 AA1 3 GLY A 329 VAL A 332 -1 N VAL A 332 O GLY A 337 SHEET 1 AA2 3 PHE B 239 ILE B 241 0 SHEET 2 AA2 3 GLY B 337 THR B 340 1 O PHE B 338 N ILE B 241 SHEET 3 AA2 3 GLY B 329 VAL B 332 -1 N MET B 330 O ILE B 339 LINK SG CYS A 275 C15 4M5 A 501 1555 1555 1.79 LINK SG CYS B 275 C15 4M5 B 501 1555 1555 1.83 CISPEP 1 LYS A 349 PRO A 350 0 6.28 CISPEP 2 LEU A 368 GLU A 369 0 -18.30 CISPEP 3 LYS B 349 PRO B 350 0 4.97 SITE 1 AC1 10 GLU A 251 CYS A 275 CYS A 276 THR A 279 SITE 2 AC1 10 SER A 280 TYR A 314 ALA A 333 GLY A 337 SITE 3 AC1 10 HIS A 440 TYR A 464 SITE 1 AC2 10 LEU B 247 GLU B 251 CYS B 275 CYS B 276 SITE 2 AC2 10 THR B 279 SER B 280 TYR B 314 VAL B 332 SITE 3 AC2 10 HIS B 440 TYR B 464 CRYST1 59.460 59.460 317.940 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016818 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016818 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003145 0.00000